vs
GE医疗（CCRN）与CORVEL CORP（CRVL）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是CORVEL CORP的1.0倍（$236.8M vs $235.6M），CORVEL CORP净利率更高（10.3% vs -35.0%，领先45.3%），CORVEL CORP同比增速更快（3.4% vs -23.6%），CORVEL CORP自由现金流更多（$35.2M vs $16.1M），过去两年CORVEL CORP的营收复合增速更高（6.6% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
Corvel Corp是一家总部位于美国的综合解决方案供应商，核心业务涵盖工伤赔偿、医疗管理与风险缓释，服务客户包括保险公司、自保雇主及公共部门机构，可帮助客户控制医疗成本、提升护理效果、优化行政运营流程。
CCRN vs CRVL — 直观对比
营收规模更大
CCRN
是对方的1.0倍
$235.6M
营收增速更快
CRVL
高出27.0%
-23.6%
净利率更高
CRVL
高出45.3%
-35.0%
自由现金流更多
CRVL
多$19.0M
$16.1M
两年增速更快
CRVL
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $235.6M |
| 净利润 | $-82.9M | $24.2M |
| 毛利率 | — | 23.3% |
| 营业利润率 | -30.2% | 13.7% |
| 净利率 | -35.0% | 10.3% |
| 营收同比 | -23.6% | 3.4% |
| 净利润同比 | -2109.7% | 1.7% |
| 每股收益（稀释后） | $-2.56 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNCRVL
| Q4 25 | $236.8M | $235.6M | ||
| Q3 25 | $250.1M | $239.6M | ||
| Q2 25 | $274.1M | $234.7M | ||
| Q1 25 | $293.4M | $231.5M | ||
| Q4 24 | $309.9M | $228.0M | ||
| Q3 24 | $315.1M | $224.4M | ||
| Q2 24 | $339.8M | $211.7M | ||
| Q1 24 | $379.2M | $207.2M |
净利润CCRNCRVL
| Q4 25 | $-82.9M | $24.2M | ||
| Q3 25 | $-4.8M | $27.9M | ||
| Q2 25 | $-6.7M | $27.2M | ||
| Q1 25 | $-490.0K | $26.4M | ||
| Q4 24 | $-3.8M | $23.8M | ||
| Q3 24 | $2.6M | $23.4M | ||
| Q2 24 | $-16.1M | $21.6M | ||
| Q1 24 | $2.7M | $19.5M |
毛利率CCRNCRVL
| Q4 25 | — | 23.3% | ||
| Q3 25 | 20.4% | 24.3% | ||
| Q2 25 | 20.4% | 24.2% | ||
| Q1 25 | 20.0% | 25.0% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | 20.4% | 22.6% | ||
| Q2 24 | 20.8% | 22.7% | ||
| Q1 24 | 20.4% | 20.9% |
营业利润率CCRNCRVL
| Q4 25 | -30.2% | 13.7% | ||
| Q3 25 | -2.4% | 15.0% | ||
| Q2 25 | -2.1% | 15.0% | ||
| Q1 25 | -0.3% | 14.4% | ||
| Q4 24 | -1.1% | 13.5% | ||
| Q3 24 | 0.9% | 12.8% | ||
| Q2 24 | -5.7% | 13.2% | ||
| Q1 24 | 0.8% | 10.9% |
净利率CCRNCRVL
| Q4 25 | -35.0% | 10.3% | ||
| Q3 25 | -1.9% | 11.6% | ||
| Q2 25 | -2.4% | 11.6% | ||
| Q1 25 | -0.2% | 11.4% | ||
| Q4 24 | -1.2% | 10.4% | ||
| Q3 24 | 0.8% | 10.4% | ||
| Q2 24 | -4.7% | 10.2% | ||
| Q1 24 | 0.7% | 9.4% |
每股收益（稀释后）CCRNCRVL
| Q4 25 | $-2.56 | $0.47 | ||
| Q3 25 | $-0.15 | $0.54 | ||
| Q2 25 | $-0.20 | $0.52 | ||
| Q1 25 | $-0.02 | $-1.23 | ||
| Q4 24 | $-0.13 | $0.46 | ||
| Q3 24 | $0.08 | $1.35 | ||
| Q2 24 | $-0.47 | $1.25 | ||
| Q1 24 | $0.08 | $1.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $230.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $322.8M | $375.7M |
| 总资产 | $449.0M | $644.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCRNCRVL
| Q4 25 | $108.7M | $230.0M | ||
| Q3 25 | $99.1M | $207.5M | ||
| Q2 25 | $81.2M | $202.0M | ||
| Q1 25 | $80.7M | $170.6M | ||
| Q4 24 | $81.6M | $162.9M | ||
| Q3 24 | $64.0M | $138.3M | ||
| Q2 24 | $69.6M | $131.9M | ||
| Q1 24 | $5.2M | $105.6M |
股东权益CCRNCRVL
| Q4 25 | $322.8M | $375.7M | ||
| Q3 25 | $408.1M | $362.8M | ||
| Q2 25 | $412.2M | $342.5M | ||
| Q1 25 | $418.2M | $322.0M | ||
| Q4 24 | $419.0M | $300.9M | ||
| Q3 24 | $424.7M | $282.8M | ||
| Q2 24 | $433.3M | $263.9M | ||
| Q1 24 | $462.4M | $247.6M |
总资产CCRNCRVL
| Q4 25 | $449.0M | $644.8M | ||
| Q3 25 | $538.2M | $611.7M | ||
| Q2 25 | $553.8M | $597.4M | ||
| Q1 25 | $576.2M | $546.0M | ||
| Q4 24 | $589.3M | $538.8M | ||
| Q3 24 | $597.4M | $518.6M | ||
| Q2 24 | $602.9M | $486.2M | ||
| Q1 24 | $648.4M | $454.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $46.1M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $35.2M |
| 自由现金流率自由现金流/营收 | 6.8% | 14.9% |
| 资本支出强度资本支出/营收 | 0.9% | 4.7% |
| 现金转化率经营现金流/净利润 | — | 1.91× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $104.3M |
8季度趋势，按日历期对齐
经营现金流CCRNCRVL
| Q4 25 | $18.2M | $46.1M | ||
| Q3 25 | $20.1M | $25.0M | ||
| Q2 25 | $4.2M | $55.0M | ||
| Q1 25 | $5.7M | $22.9M | ||
| Q4 24 | $24.2M | $41.6M | ||
| Q3 24 | $7.5M | $22.3M | ||
| Q2 24 | $82.4M | $40.4M | ||
| Q1 24 | $6.0M | $15.2M |
自由现金流CCRNCRVL
| Q4 25 | $16.1M | $35.2M | ||
| Q3 25 | $17.9M | $15.3M | ||
| Q2 25 | $2.3M | $39.5M | ||
| Q1 25 | $3.8M | $14.3M | ||
| Q4 24 | $21.7M | $32.1M | ||
| Q3 24 | $6.3M | $12.4M | ||
| Q2 24 | $79.6M | $32.8M | ||
| Q1 24 | $3.8M | $5.2M |
自由现金流率CCRNCRVL
| Q4 25 | 6.8% | 14.9% | ||
| Q3 25 | 7.2% | 6.4% | ||
| Q2 25 | 0.8% | 16.8% | ||
| Q1 25 | 1.3% | 6.2% | ||
| Q4 24 | 7.0% | 14.1% | ||
| Q3 24 | 2.0% | 5.5% | ||
| Q2 24 | 23.4% | 15.5% | ||
| Q1 24 | 1.0% | 2.5% |
资本支出强度CCRNCRVL
| Q4 25 | 0.9% | 4.7% | ||
| Q3 25 | 0.9% | 4.1% | ||
| Q2 25 | 0.7% | 6.6% | ||
| Q1 25 | 0.6% | 3.7% | ||
| Q4 24 | 0.8% | 4.2% | ||
| Q3 24 | 0.4% | 4.4% | ||
| Q2 24 | 0.8% | 3.6% | ||
| Q1 24 | 0.6% | 4.8% |
现金转化率CCRNCRVL
| Q4 25 | — | 1.91× | ||
| Q3 25 | — | 0.90× | ||
| Q2 25 | — | 2.02× | ||
| Q1 25 | — | 0.87× | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | 2.92× | 0.95× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | 2.23× | 0.78× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
CRVL
| Patient Management Services | $146.1M | 62% |
| Network Solutions Services | $89.6M | 38% |
